Capital Llc Leonite serves as Executive at Pasithea Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Capital Llc Leonite has executed 1 insider transactions totaling $71.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 19, 2022 involved purchasing 54,644 shares valued at $71.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 19, 2022 | KTTA | $71.0K | Purchase | 54,644 | $1.30 | Discretionary |
Capital Llc Leonite currently holds 54,644 shares of Pasithea Therapeutics Corp. (KTTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Llc Leonite has been a net buyer of KTTA stock. They have purchased $71.0K and sold $0 worth of shares.
Capital Llc Leonite's most recent insider trade was on Aug 19, 2022, when they purchased 54,644 shares at $1.30 per share.
Get notified when new Form 4 filings are submitted